Should We Screen Oncotype DX Eligible Patients With Breast MRI?
Publication
, Journal Article
Patel, S; Desai, NC; Goodman, S; Mango, V; Ha, R
Published in: Current Problems in Diagnostic Radiology
November 2020
Duke Scholars
Published In
Current Problems in Diagnostic Radiology
DOI
ISSN
0363-0188
Publication Date
November 2020
Volume
49
Issue
6
Start / End Page
404 / 406
Publisher
Elsevier BV
Related Subject Headings
- Nuclear Medicine & Medical Imaging
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, S., Desai, N. C., Goodman, S., Mango, V., & Ha, R. (2020). Should We Screen Oncotype DX Eligible Patients With Breast MRI? Current Problems in Diagnostic Radiology, 49(6), 404–406. https://doi.org/10.1067/j.cpradiol.2019.06.005
Patel, Sejal, Nikita Consul Desai, Sarah Goodman, Victoria Mango, and Richard Ha. “Should We Screen Oncotype DX Eligible Patients With Breast MRI?” Current Problems in Diagnostic Radiology 49, no. 6 (November 2020): 404–6. https://doi.org/10.1067/j.cpradiol.2019.06.005.
Patel S, Desai NC, Goodman S, Mango V, Ha R. Should We Screen Oncotype DX Eligible Patients With Breast MRI? Current Problems in Diagnostic Radiology. 2020 Nov;49(6):404–6.
Patel, Sejal, et al. “Should We Screen Oncotype DX Eligible Patients With Breast MRI?” Current Problems in Diagnostic Radiology, vol. 49, no. 6, Elsevier BV, Nov. 2020, pp. 404–06. Crossref, doi:10.1067/j.cpradiol.2019.06.005.
Patel S, Desai NC, Goodman S, Mango V, Ha R. Should We Screen Oncotype DX Eligible Patients With Breast MRI? Current Problems in Diagnostic Radiology. Elsevier BV; 2020 Nov;49(6):404–406.
Published In
Current Problems in Diagnostic Radiology
DOI
ISSN
0363-0188
Publication Date
November 2020
Volume
49
Issue
6
Start / End Page
404 / 406
Publisher
Elsevier BV
Related Subject Headings
- Nuclear Medicine & Medical Imaging